{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:56:59Z","timestamp":1781344619343,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.rmed.2024.107693","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T15:55:00Z","timestamp":1717689300000},"page":"107693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8747-7087","authenticated-orcid":false,"given":"Jussi","family":"Karjalainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9833-6965","authenticated-orcid":false,"given":"Ville","family":"Vartiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Tikkakoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5087-1160","authenticated-orcid":false,"given":"L. Pekka","family":"Malmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Vuotari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"L\u00e4helm\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Sairanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-3997","authenticated-orcid":false,"given":"Mikko","family":"Vahteristo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1586-4998","authenticated-orcid":false,"given":"Lauri","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.rmed.2024.107693_bib1","article-title":"Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma","author":"Cates","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.rmed.2024.107693_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","article-title":"Systematic review of errors in inhaler use: has patient technique improved over time?","volume":"150","author":"Sanchis","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/17425240802637862","article-title":"Targeting drugs to the airways: the role of spacer devices","volume":"6","author":"Lavorini","year":"2009","journal-title":"Expert Opin Drug Deliv."},{"issue":"10","key":"10.1016\/j.rmed.2024.107693_bib4","first-page":"1313","article-title":"Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler","volume":"50","author":"Geller","year":"2005","journal-title":"Respir. Care"},{"issue":"4","key":"10.1016\/j.rmed.2024.107693_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s41030-023-00239-7","article-title":"Cradle-to-Grave emission reduction for easyhaler dry powder inhaler product portfolio","volume":"9","author":"Inget","year":"2023","journal-title":"Pulm Ther"},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thoraxjnl-2019-213744","article-title":"Carbon footprint impact of the choice of inhalers for asthma and COPD","volume":"75","author":"Janson","year":"2020","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000109374","article-title":"Dry powder inhalers: which factors determine the frequency of handling errors?","volume":"75","author":"Wieshammer","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2024.107693_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1183\/23120541.00701-2020","article-title":"ICS-formoterol reliever versus ICS and short-acting \u03b22-agonist reliever in asthma: a systematic review and meta-analysis","volume":"7","author":"Hatter","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2024.107693_bib9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting \u03b2-Agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2024.107693_bib10","first-page":"CD013518","article-title":"Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma","volume":"5","author":"Crossingham","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.rmed.2024.107693_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/rmed.2000.0788","article-title":"Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI","volume":"94","author":"Seberov\u00e1","year":"2000","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1465-9921-7-141","article-title":"Onset of relief of dyspnoea with budesonide\/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study","volume":"7","author":"Jonkers","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2024.107693_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pupt.2005.04.009","article-title":"Efficacy and safety of budesonide\/formoterol compared with salbutamol in the treatment of acute asthma","volume":"19","author":"Balanag","year":"2006","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.rmed.2024.107693_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01526-2016","article-title":"ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests","volume":"49","author":"Coates","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.rmed.2024.107693_bib15","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2024.107693_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4037\/ajcc1998.7.3.200","article-title":"Validity of the numeric rating scale as a measure of dyspnea","volume":"7","author":"Gift","year":"1998","journal-title":"Am. J. Crit. Care"},{"issue":"5","key":"10.1016\/j.rmed.2024.107693_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/COPD.S11474","article-title":"Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters","volume":"9","author":"Malmberg","year":"2010","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2024.107693_bib18","doi-asserted-by":"crossref","unstructured":"Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials.","DOI":"10.1016\/j.ijsu.2010.09.006"},{"key":"10.1016\/j.rmed.2024.107693_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1081-1206(10)62275-2","article-title":"Once daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma","volume":"84","author":"Nayak","year":"2000","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2024.107693_bib20","doi-asserted-by":"crossref","unstructured":"M. Bonini, M. Di Paolo, D. Bagnasco, I. Baiardini, F. Braido, M. Caminati, et al., Minimal clinically important difference for asthma endpoints: an expert consensus report, Eur. Respir. Rev. 29 (156) (2020 Jun 3) 190137.","DOI":"10.1183\/16000617.0137-2019"},{"issue":"2","key":"10.1016\/j.rmed.2024.107693_bib21","first-page":"178","article-title":"A novel multiple dose powder inhaler. Salbutamol powder and aerosol give equal bronchodilatation with equal doses","volume":"72","author":"Haahtela","year":"1994","journal-title":"Ann. Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000196301","article-title":"Easyhaler, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to use","volume":"61","author":"Nieminen","year":"1994","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2024.107693_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/02786829408959751","article-title":"Easyhaler multiple dose powder inhaler \u2013 practical and effective alternative to the pressurized MDI","volume":"22","author":"Vidgren","year":"1995","journal-title":"Aerosol. Sci. Technol."},{"key":"10.1016\/j.rmed.2024.107693_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00044011-200019050-00003","article-title":"Salbutamol via easyhaler multidose dry powder inhaler produces equivalent relief of histamine-induced bronchoconstriction to salbutamol via pressurised metered-dose inhaler","volume":"19","author":"Randell","year":"2000","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.rmed.2024.107693_bib25","first-page":"25","article-title":"Comparison of salbutamol efficacy in children-via the metered-dose inhaler (MDI) with Volumatic spacer and via the dry powder inhaler, Easyhaler, with the nebulizer--in mild to moderate asthma exacerbation: a multicenter, randomized study","volume":"29","author":"Direkwatanachai","year":"2011","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.rmed.2024.107693_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1399-3038.1999.101002.x","article-title":"Application and efficacy of the multi-dose powder inhaler, Easyhaler, in children with asthma","volume":"10","author":"Malmstr\u00f6m","year":"1999","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.rmed.2024.107693_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.115.2.343","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma","volume":"115","author":"Gross","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107693_bib28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1067\/mai.2000.107037","article-title":"Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids","volume":"105","author":"Wolfe","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2024.107693_bib29","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1067\/mai.2000.105711","article-title":"Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial","volume":"105","author":"Kavuru","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2024.107693_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1185\/03007995.2013.772506","article-title":"Efficacy and safety profile of fluticasone\/formoterol combination therapy compared to its individual components administered concurrently in asthma: a Randomized controlled trial","volume":"29","author":"Bodzenta-Lukaszyk","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pupt.2006.11.003","article-title":"Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthma","volume":"21","author":"Otto-Knapp","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2024.107693_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1399-3003.1999.14a06.x","article-title":"What are minimal important changes for asthma measures in a clinical trial?","volume":"14","author":"Santanello","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2024.107693_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jemermed.2008.01.012","article-title":"Characteristics of spacer device use by patients with asthma and COPD","volume":"35","author":"Guss","year":"2008","journal-title":"J. Emerg. Med."},{"issue":"12","key":"10.1016\/j.rmed.2024.107693_bib34","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1211\/jpp.60.12.0006","article-title":"Salbutamol relative lung and systemic bioavailability of large and small spacers","volume":"60","author":"Mazhar","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"issue":"11","key":"10.1016\/j.rmed.2024.107693_bib35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00228-001-0382-9","article-title":"Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser","volume":"57","author":"Silkstone","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.rmed.2024.107693_bib36","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jaip.2020.09.026","article-title":"Peak inspiratory flow measured at different inhaler resistances in patients with asthma","volume":"9","author":"Haughney","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"12","key":"10.1016\/j.rmed.2024.107693_bib37","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.rmed.2004.04.010","article-title":"The course of inhalation profiles during an exacerbation of obstructive lung disease","volume":"98","author":"Broeders","year":"2004","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4155\/tde.13.132","article-title":"Dry-powder inhalers in acute asthma","volume":"5","author":"Selroos","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.rmed.2024.107693_bib39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2024.107693_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ajem.2006.09.006","article-title":"Clinical measures associated with FEV1 in persons with asthma requiring hospital admission","volume":"25","author":"Arnold","year":"2007","journal-title":"Am. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.rmed.2024.107693_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.rmed.2007.11.009","article-title":"Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases","volume":"102","author":"van den Broek","year":"2008","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2024.107693_bib42","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1164\/ajrccm.160.4.9806101","article-title":"et al.,Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methacholine","volume":"160","author":"Ahrens","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2024.107693_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2125.2006.02641.x","article-title":"Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism","volume":"62","author":"Lavorini","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.rmed.2024.107693_bib44","doi-asserted-by":"crossref","unstructured":"N. Kearns, M. Williams, P. Bruce, M. Black, C. Kearns, J. Sparks, et al., Single dose of budesonide\/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial,Thorax. 2022 Jul 18:thoraxjnl-2022-219052. doi: 10.1136\/thorax-2022-219052.","DOI":"10.1136\/thorax-2022-219052"},{"issue":"2","key":"10.1016\/j.rmed.2024.107693_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00151829-200504020-00006","article-title":"Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler","volume":"4","author":"Ankerts","year":"2005","journal-title":"Treat. Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2024.107693_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/pulp.1996.0031","article-title":"Speeds of action of single doses of formoterol and salbutamol compared with placebo in reversing methacholine-induced bronchoconstriction","volume":"9","author":"Beach","year":"1996","journal-title":"Pulm. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00044011-200020010-00004","article-title":"In vitro comparison of three salbutamol-containing multidose dry powder inhalers","volume":"20","author":"Palander","year":"2000","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.rmed.2024.107693_bib48","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s12325-019-01066-6","article-title":"Understanding dry powder inhalers: key technical and patient preference attributes","volume":"36","author":"Levy","year":"2019","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.rmed.2024.107693_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/jamp.2017.1416","article-title":"Peak inspiratory flow rate in chronic obstructive pulmonary disease: implications for dry powder inhalers","volume":"30","author":"Ghosh","year":"2017","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"1","key":"10.1016\/j.rmed.2024.107693_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s41030-023-00246-8","article-title":"Successful use of Easyhaler\u00ae dry powder inhaler in patients with chronic obstructive pulmonary disease; analysis of peak inspiratory flow from three clinical trials","volume":"10","author":"Kainu","year":"2024","journal-title":"Pulm Ther"}],"updated-by":[{"DOI":"10.1016\/j.rmed.2024.107715","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000}}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T20:24:32Z","timestamp":1728246272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"alternative-id":["S0954611124001677"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107693","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.rmed.2024.107715","asserted-by":"object"}]},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107693"}}